NEWS
AIFA – Impact of simplified procedures introduced in 2020 on the negotiation of medicinal products
In October 2020, the ‘Procedura semplificata di prezzo e rimborso per i farmaci equivalenti/biosimilari (generici)’ [Simplified price and...
Webinar Replay: AMNOG impact on European countries?!
Watch our webinar replay : AMNOG impact on European countries?! Dr. Stefan Walzer discussed this issue together with country experts across Europe.
Webinar : What does the Brexit effect mean for UK patient access?
Join our webinar : What does the Brexit effect mean for UK patient access? on march 29 2022.
ABOUT US
We have the ability to foster effective collaborations between specialized consultancies across Europe
- A European wide consultancy group founded by 4 locally grounded firms
- One multifunctional and integrated team
- We address the market access and public affairs needs of pharmaceutical, biotech and medical devices companies across European markets
- Our registered status allows our clients to contract with MEDVANCE as a legal entity
What do we offer ?
- Strategic market access and pricing advice
- Local HTA submission and negotiation support
- Combined market access and public affairs strategies
- Strategic deployment support and advice in European healthcare markets
5
Locations
In the main healthcare markets
80
PEOPLE
Across Europe
+300
PROJECTS AND INITIATIVES IN 2017
Across various HEALTHCARE SECTORS
PUBLICATIONS
Posters and other publications
Medvance’s expertise in European and country specific Market Access is represented in our participation in international conferences. During those conferences, such as ISPOR Europe or BIO International convention, experts from our teams analyze and summarize the European trends for Market access in posters. This section regroups all the posters accepted and presented during those conferences.
